Salutari V - Search Results

1

Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.

Musacchio L, Boccia S, Marchetti C, Minucci A, Camarda F, Cassani C, Ventriglia J, Salutari V, Ghizzoni V, Giudice E, Perri MT, Carbone MV, Ricci C, Pignata S, Fagotti A, Scambia G, Lorusso D. Musacchio L, et al. Among authors: salutari v. Int J Gynecol Cancer. 2023 Jun 5;33(6):922-928. doi: 10.1136/ijgc-2022-003903. Int J Gynecol Cancer. 2023. PMID: 36759000

2

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications.

Ferrandina G, Lauriola L, Zannoni GF, Distefano MG, Legge F, Salutari V, Gessi M, Maggiano N, Scambia G, Ranelletti FO. Ferrandina G, et al. Among authors: salutari v. Br J Cancer. 2002 Nov 4;87(10):1145-52. doi: 10.1038/sj.bjc.6600578. Br J Cancer. 2002. PMID: 12402155 Free PMC article.

3

Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma.

Testa AC, Ferrandina G, Distefano M, Fruscella E, Mansueto D, Basso D, Salutari V, Scambia G. Testa AC, et al. Among authors: salutari v. Ultrasound Obstet Gynecol. 2004 Sep;24(4):445-52. doi: 10.1002/uog.1703. Ultrasound Obstet Gynecol. 2004. PMID: 15343602 Free article. Clinical Trial.

4

Biological characterization of ovarian cancer: prognostic and therapeutic implications.

Legge F, Ferrandina G, Salutari V, Scambia G. Legge F, et al. Among authors: salutari v. Ann Oncol. 2005 May;16 Suppl 4:iv95-101. doi: 10.1093/annonc/mdi916. Ann Oncol. 2005. PMID: 15923439 Free article. Review. No abstract available.

5

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.

Ferrandina G, Ludovisi M, De Vincenzo R, Salutari V, Lorusso D, Colangelo M, Prantera T, Valerio MR, Scambia G. Ferrandina G, et al. Among authors: salutari v. Ann Oncol. 2007 Aug;18(8):1348-53. doi: 10.1093/annonc/mdm136. Epub 2007 Apr 29. Ann Oncol. 2007. PMID: 17470449 Free article. Clinical Trial.

6

The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries.

Testa AC, Mancari R, Di Legge A, Mascilini F, Salutari V, Scambia G, Ferrandina G. Testa AC, et al. Among authors: salutari v. Ultrasound Obstet Gynecol. 2008 Feb;31(2):218-21. doi: 10.1002/uog.5251. Ultrasound Obstet Gynecol. 2008. PMID: 18254156 Free article.

7

Successful multimodal treatment of a breast cancer patient with a recurrence invading the chest wall.

Corrado G, di Stefano A, Salutari V, Piraino A, Margaritora S, Lucidi A, Scambia G, Ferrandina G. Corrado G, et al. Among authors: salutari v. J Chemother. 2011 Feb;23(1):49-52. doi: 10.1179/joc.2011.23.1.49. J Chemother. 2011. PMID: 21482496

8

Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.

Ferrandina G, Distefano MG, De Vincenzo R, Salutari V, Petrillo M, Scarciglia ML, Pietragalla A, Conte C, Scambia G. Ferrandina G, et al. Among authors: salutari v. Gynecol Oncol. 2013 Mar;128(3):518-23. doi: 10.1016/j.ygyno.2012.12.003. Epub 2012 Dec 10. Gynecol Oncol. 2013. PMID: 23237767

9

Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study.

Petrillo M, Amadio G, Salutari V, Paris I, Di Stefano MG, Ferandina G, Scambia G, Fagotti A. Petrillo M, et al. Among authors: salutari v. Gynecol Oncol. 2016 Aug;142(2):231-6. doi: 10.1016/j.ygyno.2016.05.017. Epub 2016 May 26. Gynecol Oncol. 2016. PMID: 27215633

10

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.

Piccirillo MC, Scambia G, Bologna A, Signoriello S, Vergote I, Baumann K, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Gallo C, Pignata S, Perrone F. Piccirillo MC, et al. Among authors: salutari v. Ann Oncol. 2018 May 1;29(5):1189-1194. doi: 10.1093/annonc/mdy062. Ann Oncol. 2018. PMID: 29462248 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page